Antihistamine Withdrawal Itch: Understanding Rebound Pruritus After Long-Term Cetirizine or Levocetirizine Use

“Patients who stop long-term daily use of cetirizine or levocetirizine after months or years may suddenly develop severe, widespread itching within days, even if they never had itch before starting the medicine.”

This rare but clinically important reaction has gained attention following a 2025 FDA safety warning. At The Skin Care Network, our dermatologist helps patients manage allergy-related skin symptoms safely while minimising the risk of rebound effects.

Key Areas We Will Cover

• What does rebound pruritus and urticaria mean after stopping antihistamines
• The FDA warning on the discontinuation of cetirizine and levocetirizine
• Who is most at risk, and typical timeline of symptoms
• Evidence from recent studies and scoping reviews
• Most effective management strategies
• Practical advice for safe tapering or switching in the UK
• When to seek professional dermatology support

What Is Rebound Pruritus After Stopping Antihistamines?

Rebound pruritus refers to new or worsened severe itching (and sometimes hives) that appears shortly after discontinuing long-term use of certain antihistamines, particularly cetirizine or levocetirizine.

This reaction occurs in patients who used the medication daily for months to years and had no prior history of significant itch. Symptoms typically emerge within 1 to 5 days of stopping and can be widespread and distressing enough to require medical intervention. Importantly, this effect appears specific to cetirizine and levocetirizine so far, with no similar reports for other common antihistamines.

What Does the FDA Warning Say About Cetirizine and Levocetirizine?

In May 2025, the FDA issued a safety communication requiring new warnings on both prescription and over-the-counter cetirizine (Zyrtec) and levocetirizine (Xyzal) labels regarding the risk of severe pruritus after long-term use.

The agency highlighted rare but serious cases of intense itching that may start days after stopping the medicine. Updated prescribing information notes that symptoms often improve upon restarting the same antihistamine. The warning aims to increase awareness among patients and healthcare professionals, especially those using these medications for chronic allergies or urticaria.

Who Is at Risk of Antihistamine Rebound Itch and When Does It Occur?

Rebound symptoms mainly affect long-term daily users of cetirizine or levocetirizine, with a clear female predominance and onset typically 1–5 days after abrupt discontinuation.

Available data show:

• Age range from 6 to 71 years
• Female patients comprise about 76% of reported cases
• Duration of use: from several months to many years
• Concomitant urticaria (hives) developed in a notable subset of patients

No reports of rebound pruritus have been linked to other first- or second-generation antihistamines in the reviewed literature. The exact mechanism remains unclear but may involve a form of histamine rebound or unmasking of underlying sensitivity.

What Do Recent Studies Reveal About This Condition?

A 2025–2026 scoping review identified limited but consistent evidence from two retrospective studies, one case series, and one case report, confirming rebound pruritus primarily with cetirizine (327 cases) and levocetirizine (39 cases).

Studies originated from the United States, the Netherlands, and Singapore. Among affected individuals, 85 also experienced urticaria. The review underscores significant gaps in understanding risk factors, the full clinical course, and optimal prevention strategies, highlighting the need for more robust research.

How Should Rebound Itch Be Managed After Antihistamine Withdrawal?

Restarting cetirizine or levocetirizine at the previous dose is the most effective strategy, resolving symptoms in 99.2% of cases (136 out of 137 patients).

Other approaches show lower success rates:

• Gradual tapering of the antihistamine: only 33.3% resolution (11 out of 33 patients)
• Alternative treatments: variable results, often requiring specialist input

At The Skin Care Network, our dermatologist evaluates each case individually. We may recommend a supervised taper, a switch to a different antihistamine class, or short-term supportive therapies (such as topical treatments or other systemic options) while addressing any underlying skin condition.

How Can UK Patients Safely Manage Long-Term Antihistamine Use?

If you rely on daily cetirizine or levocetirizine for allergies, hay fever, or chronic urticaria, do not stop suddenly without medical advice. Gradual reduction under supervision may help reduce risk, though evidence suggests it is less reliable than restarting if rebound occurs.

Our Barnet clinic offers expert assessment for patients experiencing rebound itch or those planning to discontinue long-term antihistamines. We provide personalised plans that balance symptom control with safety, including alternatives where appropriate.

Conclusion

Rebound pruritus after stopping long-term cetirizine or levocetirizine is a rare but real adverse effect that can cause significant discomfort. Awareness of the 2025 FDA warning, combined with evidence from recent reviews, helps patients and clinicians make informed decisions. Most cases respond well to restarting the medication, while prevention through careful management is preferable. Always consult a healthcare professional before changing long-term therapy.

Get Started Today

Concerned about rebound itch, hives, or planning to adjust your antihistamine regimen? Book a consultation with our experienced dermatologist at The Skin Care Network. We provide safe, evidence-based guidance tailored to your needs.

📞 Call +44 20 8441 1043 or visit us at 68-70 Union St, Barnet EN5 4HZ. Take the first step towards comfortable, well-managed skin health today.

Frequently Asked Questions About Antihistamine Rebound Itch